Skip to content

EBITDA at other companies

LeMaitre Vascular logo
LeMaitre VascularLMAT
$20.4M+34.4%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$36.24M-47.4%
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

$8.1Mebit+
$3.3MDepreciation Depletion & Amortization
=-$4.8M

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's EBITDA?
Vericel (VCEL) reported EBITDA of -$4.8M in Q1 2026.
How has Vericel's EBITDA changed year-over-year?
Vericel's EBITDA increased by 52.5% year-over-year, from -$10.11M to -$4.8M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.